ACS & MI

The ACS Spectrum and Pathophysiology Framework

Acute Coronary Syndrome (ACS) represents a spectrum of clinical presentations ranging from unstable angina (UA) to acute myocardial infarction (MI). It is a leading cause of emergency department visits and a top contributor to morbidity and mortality in the United States ^[1]. For the Certified Emergency Nurse (CEN) exam, mastering the rapid differentiation, immediate management, and life-threatening complications of ACS is critical. The emergency nurse's ability to recognize subtle presentations and execute time-sensitive interventions directly impacts patient survival and myocardial salvage.

Subtypes of ACS and Their Defining Mechanisms

The ACS Spectrum

Understanding the pathological continuum of coronary artery disease is essential. The trigger for all ACS subtypes is the acute rupture or erosion of an atherosclerotic plaque.

• Unstable Angina (UA): Ischemia without myocardial necrosis. Chest pain occurs at rest or with minimal exertion. Cardiac biomarkers (troponin) are negative.
• Non-ST-Elevation Myocardial Infarction (NSTEMI): Ischemia causing sufficient myocardial damage to release biomarkers (troponin elevation). ECG typically shows ST-segment depression or T-wave inversion, but no ST elevation ^[2].
• ST-Elevation Myocardial Infarction (STEMI): Transmural ischemia causing extensive myocardial necrosis. ECG shows characteristic ST-segment elevation in contiguous leads. This is the highest-acuity ACS requiring immediate reperfusion ^[1].

Pathophysiology

• Atherosclerosis: The underlying chronic process involving lipid deposition, inflammation, and plaque formation in the coronary arteries.
• Plaque Rupture: The acute event that exposes the highly thrombogenic subendothelial matrix to circulating blood.
• Coronary Thrombosis: Platelet adhesion, activation, and aggregation, followed by fibrin cross-linking, creating an occlusive (STEMI) or sub-occlusive (NSTEMI/UA) thrombus ^[5].
• Myocardial Necrosis: Irreversible cell death that begins within 20-40 minutes of total coronary occlusion.

The Ischemic Cascade and Critical Time Goals

The Ischemic Cascade

This sequence of events occurs before irreversible damage, offering a window for intervention. The emergency nurse must recognize that chest pain is a late sign.

1. Supply-demand mismatch (e.g., tachycardia, hypotension, hypoxia).
2. Diastolic dysfunction (earliest sign of ischemia).
3. Systolic dysfunction.
4. ECG changes (ST/T wave abnormalities).
5. Chest pain.
6. Biomarker elevation (indicating myocardial necrosis).

Time is Muscle

Total ischemic time is the single most powerful predictor of outcomes. The CEN exam emphasizes these critical time metrics for STEMI patients:

• Door-to-ECG: ≤10 minutes ^[1].
• Door-to-Balloon (PCI): ≤90 minutes for patients presenting to a PCI-capable hospital.
• Door-to-Needle (Fibrinolysis): ≤30 minutes if PCI cannot be performed within 120 minutes ^[1].

Classic and Atypical Symptom Patterns in ACS

Typical Presentation

• Pain Description: Substernal chest pressure, squeezing, heaviness, or tightness. Radiation to the left arm, neck, jaw, or back.
• Associated Symptoms: Dyspnea, diaphoresis, nausea/vomiting, indigestion, and profound weakness.

Atypical Presentation (High-Yield for CEN)

Emergency nurses must have a high index of suspicion for atypical presentations, which are more common in specific populations.

• Women: More likely to report sharp or burning epigastric pain, fatigue, indigestion, or palpitations without classic chest pressure ^[3].
• Diabetics: Autonomic neuropathy can mask pain. Look for "silent ischemia" presenting as sudden dyspnea, weakness, or syncope.
• Elderly: Often present with confusion, profound acute weakness, shortness of breath, or a sudden change in mental status.

12-Lead ECG Criteria, Biomarker Standards, and HEART Score

12-Lead ECG Interpretation

Obtain and interpret the ECG within 10 minutes of patient arrival. This is a non-negotiable emergency nursing competency.

• STEMI Criteria: ST-segment elevation at the J-point in two contiguous leads.
  • Leads V2-V3: ≥2 mm in men, ≥1.5 mm in women.
  • All other leads: ≥1 mm.
• Reciprocal Changes: ST depression in leads opposite the infarct. Example: Inferior STEMI (II, III, aVF) often shows reciprocal depression in I and aVL. This confirms the diagnosis ^[5].
• Localization of Infarct:
  • Septal: V1-V2
  • Anterior: V3-V4
  • Lateral: I, aVL, V5-V6
  • Inferior: II, III, aVF
  • Posterior: Isolated ST depression in V1-V3. Obtain V7, V8, V9 to confirm.
  • Right Ventricular: ST elevation in V4R. Critical: Suspect in any inferior MI. Obtain a right-sided ECG. Nitrates are contraindicated in RVMI.
• NSTEMI/UA: Look for ST-segment depression, T-wave inversion, or non-diagnostic changes.

Cardiac Biomarkers

• Troponin (I or T): The gold standard. Highly specific and sensitive for myocardial injury. Rises within 2-4 hours of injury and peaks at 24-48 hours. Any elevation above the 99th percentile is considered abnormal and defines an MI ^[2].
• CK-MB: Historical marker. Rises in 4-6 hours. Less specific than troponin. May be used to detect reinfarction.

Risk Stratification

The HEART Score is a validated ED tool to predict 6-week risk of Major Adverse Cardiac Events (MACE).

Pharmacologic and Reperfusion Strategies for ACS

Immediate Assessment and Stabilization (BLS/ACLS)

1. Airway/Breathing: Administer oxygen only if SpO₂ is <90% or if the patient is in respiratory distress. Routine oxygen is potentially harmful due to vasoconstriction ^[1].
2. Circulation: Establish large-bore IV access x 2. Continuous cardiac monitoring. Obtain a full set of vital signs.
3. 12-Lead ECG: Obtain and interpret, or transmit for interpretation, within 10 minutes.

Pharmacology for ACS

• Aspirin: 162-325 mg. Chewed and swallowed. (Class I recommendation).
• Nitroglycerin (NTG): 0.4 mg SL every 5 minutes for up to 3 doses for chest pain.
  • Contraindications: Hypotension (SBP < 90 mmHg), severe bradycardia, suspected RV infarct, or use of PDE-5 inhibitors (Viagra, Cialis, Levitra) within 24-48 hours ^[5].
• Morphine Sulfate: 2-4 mg IV for pain unrelieved by NTG. Use with caution; it can cause hypotension and respiratory depression.
• Antiplatelet Therapy:
  • P2Y12 inhibitors: Clopidogrel (Plavix) or Ticagrelor (Brilinta) loading dose given before PCI ^[1].
• Anticoagulation:
  • Unfractionated Heparin (UFH) or Low Molecular Weight Heparin (Enoxaparin) is administered to prevent further thrombus propagation.

Reperfusion Therapy (STEMI)

• Primary Percutaneous Coronary Intervention (PCI): The gold standard. Goal is door-to-balloon time ≤90 minutes.
• Fibrinolysis (e.g., Tenecteplase, Alteplase): Indicated if PCI is not available within 120 minutes.
  • Absolute Contraindications: Any prior intracranial hemorrhage (ICH), known malignant intracranial neoplasm, active bleeding, or recent major surgery/trauma.

Common Complications and Medication Safety Alerts

Alert: Life-Threatening Complications

• Dysrhythmias: Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF) are the leading causes of death in the first hours of an MI. Be prepared for defibrillation and ACLS protocols. Monitor for bradycardias and heart blocks, especially with inferior MI.
• Cardiogenic Shock: Signs include persistent hypotension, decreased level of consciousness, cool clammy skin, and pulmonary edema. Treatment involves inotropes (Dobutamine), vasopressors (Norepinephrine), and intra-aortic balloon pump (IABP) support.
• Mechanical Complications (Days 3-7 post-MI): Ventricular septal rupture (new harsh holosystolic murmur, sudden CHF), papillary muscle rupture (acute mitral regurgitation, pulmonary edema), and free wall rupture (electromechanical dissociation, sudden death). These are surgical emergencies.
• Pericarditis (Dressler's Syndrome): A late complication presenting with pleuritic chest pain that improves when leaning forward.

Medication Safety

• RV Infarct: Patients with inferior MI are at high risk. Always check V4R. If RVMI is present, aggressive fluid resuscitation (not NTG) is the first line for hypotension.
• NSTEMI in the Elderly: Older adults have a higher risk of bleeding from anticoagulant and antiplatelet therapies. Use weight-based dosing for heparin and check for fall risk.

Priority Setting and Common Exam Pitfalls

• Prioritization: The patient with chest pain, diaphoresis, and ST elevation on the ECG is the highest priority patient in the entire ED. They take precedence over nearly every other patient.
• Memory Aid for NTG Contraindications: "The patient is DOWN and took a PDE-5 last night." (Hypotension, RV infarct, Sildenafil/Tadalafil).
• Atypical Presentations: The CEN exam frequently tests your ability to recognize ACS in women, diabetics, and the elderly. If a patient has unexplained dyspnea, weakness, or altered mental status, always suspect ACS until proven otherwise.
• Lead Placement: Know your leads. If you see an Inferior MI (II, III, aVF), your next immediate nursing action is to obtain a right-sided ECG (V4R) to rule out RV infarction.
• Fibrinolytics: A common pitfall is forgetting the contraindications. If the question states the patient hit their head or has a history of brain cancer, do not choose fibrinolytics.

References & Sources

1. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-e425. https://doi.org/10.1161/CIR.0b013e3182742cf6
2. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344-e426. https://doi.org/10.1161/CIR.0000000000000134
3. Mehta LS, Beckie TM, DeVon HA, et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016;133(9):916-947. https://doi.org/10.1161/CIR.0000000000000351
4. Emergency Nurses Association. Sheehy's Manual of Emergency Care. 8th ed. Elsevier; 2020.
5. Tintinalli JE, Ma OJ, Yealy DM, et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. 9th ed. McGraw-Hill Education; 2020.
6. Hollander JE, Than M, Mueller C. State-of-the-Art Evaluation of Emergency Department Patients With Potential Acute Coronary Syndromes. Circulation. 2016;134(7):547-564. https://doi.org/10.1161/CIRCULATIONAHA.116.021814